New Big Data Study From MIT Puts Clinical Trial Success Rate at 14 Percent

Drug Industry Daily
Nearly 14 percent of all drugs in clinical trials eventually win approval from the FDA — a much higher percentage than previously thought, according to a new study from the MIT Sloan School of Management.

To View This Article:


Subscribe To Drug Industry Daily